USP11
Ubiquitin carboxyl-terminal hydrolase 11
Also known as: UBP11_HUMAN, UHX1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P51784
- Gene
- USP11
- Ensembl
- ENSG00000102226
- Chromosome
- X
- Canonical length
- 963 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Protein ubiquitination controls many intracellular processes, including cell cycle progression, transcriptional activation, and signal transduction. This dynamic process, involving ubiquitin conjugating enzymes and deubiquitinating enzymes, adds and removes ubiquitin. Deubiquitinating enzymes are cysteine proteases that specifically cleave ubiquitin from ubiquitin-conjugated protein substrates. This gene encodes a deubiquitinating enzyme which lies in a gene cluster on chromosome Xp11.23 [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
963 residues, UniProt reviewed canonical sequence.
>P51784|USP11
1 MAVAPRLFGG LCFRFRDQNP EVAVEGRLPI SHSCVGCRRE RTAMATVAAN PAAAAAAVAA
61 AAAVTEDREP QHEELPGLDS QWRQIENGES GRERPLRAGE SWFLVEKHWY KQWEAYVQGG
121 DQDSSTFPGC INNATLFQDE INWRLKEGLV EGEDYVLLPA AAWHYLVSWY GLEHGQPPIE
181 RKVIELPNIQ KVEVYPVELL LVRHNDLGKS HTVQFSHTDS IGLVLRTARE RFLVEPQEDT
241 RLWAKNSEGS LDRLYDTHIT VLDAALETGQ LIIMETRKKD GTWPSAQLHV MNNNMSEEDE
301 DFKGQPGICG LTNLGNTCFM NSALQCLSNV PQLTEYFLNN CYLEELNFRN PLGMKGEIAE
361 AYADLVKQAW SGHHRSIVPH VFKNKVGHFA SQFLGYQQHD SQELLSFLLD GLHEDLNRVK
421 KKEYVELCDA AGRPDQEVAQ EAWQNHKRRN DSVIVDTFHG LFKSTLVCPD CGNVSVTFDP
481 FCYLSVPLPI SHKRVLEVFF IPMDPRRKPE QHRLVVPKKG KISDLCVALS KHTGISPERM
541 MVADVFSHRF YKLYQLEEPL SSILDRDDIF VYEVSGRIEA IEGSREDIVV PVYLRERTPA
601 RDYNNSYYGL MLFGHPLLVS VPRDRFTWEG LYNVLMYRLS RYVTKPNSDD EDDGDEKEDD
661 EEDKDDVPGP STGGSLRDPE PEQAGPSSGV TNRCPFLLDN CLGTSQWPPR RRRKQLFTLQ
721 TVNSNGTSDR TTSPEEVHAQ PYIAIDWEPE MKKRYYDEVE AEGYVKHDCV GYVMKKAPVR
781 LQECIELFTT VETLEKENPW YCPSCKQHQL ATKKLDLWML PEILIIHLKR FSYTKFSREK
841 LDTLVEFPIR DLDFSEFVIQ PQNESNPELY KYDLIAVSNH YGGMRDGHYT TFACNKDSGQ
901 WHYFDDNSVS PVNENQIESK AAYVLFYQRQ DVARRLLSPA GSSGAPASPA CSSPPSSEFM
961 DVNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against USP11 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 169 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 169 nTPM
- basal ganglia: 145 nTPM
- hypothalamus: 133 nTPM
- cerebellum: 114 nTPM
- pituitary gland: 105 nTPM
- amygdala: 99 nTPM
Single-cell type
- undifferentiated spermatogonia: 133 nCPM
- retinal bipolar cells: 130 nCPM
- other brain neurons: 125 nCPM
- brain inhibitory neurons: 107 nCPM
- retinal amacrine cells: 101 nCPM
- corticotrophs: 97 nCPM
Immune cell
- naive CD8 T-cell: 77 nTPM
- basophil: 64 nTPM
- NK-cell: 56 nTPM
- gdT-cell: 56 nTPM
- memory CD8 T-cell: 54 nTPM
- memory B-cell: 53 nTPM
Brain region
- hypothalamus: 350 nTPM
- basal ganglia: 281 nTPM
- cerebral cortex: 276 nTPM
- pons: 239 nTPM
- midbrain: 207 nTPM
- thalamus: 206 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about USP11.
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 176 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Abnormal brain morphology
- Dynein arm defect of respiratory motile cilia
- Absent inner and outer dynein arms
- Abnormal ciliary motility
- Bronchiectasis
Disease | ImmuneIEDB
Conditions an epitope on USP11 was assayed in.
- glioblastoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.17
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.57
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- cysteine-type deubiquitinase activity
- cysteine-type endopeptidase activity
- transcription corepressor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Peptidase C19, ubiquitin carboxyl-terminal hydrolase
- Peptidase C19, ubiquitin-specific peptidase, DUSP domain
- Ubiquitin specific protease, conserved site
- Ubiquitin-like domain, USP-type
- Ubiquitin specific protease UPS, catalytic domain
- Ubiquitin carboxyl-terminal hydrolase, C-terminal
- DUSP-like superfamily
- Papain-like cysteine peptidase superfamily
- Ubiquitin carboxyl-terminal hydrolase
- Ubiquitin carboxyl-terminal hydrolase
- DUSP domain
- Ubiquitin-specific protease C-terminal
- Ubiquitin-like domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of USP11 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads USP11 as an antibody target. Whether an autoantibody or antibody against USP11 could matter depends on whether native USP11 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
USP11 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label USP11 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...